Single vs. Dual Implant Fixation for Distal Femur Fractures in Older or Compromised Adults
Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Apr 17, 2025
Trial Information
Current as of May 15, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see which type of surgical treatment works better for older adults or those with certain health issues who have broken their thigh bone (distal femur fractures). The two treatments being compared are single implant fixation (SIF) and dual implant fixation (DIF). The main goals are to find out if using two implants (DIF) helps patients recover better than using one (SIF) and to understand how easy it is to recruit and keep participants in the study.
To participate, individuals should be at least 60 years old or between 18-60 with specific health concerns like osteoporosis or obesity. Participants will be randomly assigned to receive either SIF or DIF and will need to visit the clinic for follow-ups to check on their recovery and bone healing. It’s important to note that the trial is not yet recruiting participants, but if you or a family member are eligible and interested, it could provide valuable information about the best ways to treat this type of fracture.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Isolated DFF (native AO/OTA-type A2, A3, C or periprosthetic Lewis and
- Rorabeck type 1, 2) and either:
- • 1. Age ≥ 60 years or;
- 2. Age 18-60 years with one or more of:
- • i. Osteoporosis ii. Obesity (Body Mass Index \>30) iii. Metaphyseal comminution iv. Diabetes
- • 2. Fracture amenable to plating and nailing
- • 3. Ability to read and speak English or availability of a translator
- • 4. Acute fractures (within 14-days of injury)
- • 5. No surgeon preference regarding SIF vs. DIF
- • 6. Provision of informed consent
- Exclusion Criteria:
- • 1. Candidate for primary or revision arthroplasty (surgeon opinion)
- • 2. Periprosthetic fracture with loose implant
- • 3. Gustillo grade III open fractures
- • 4. Ipsilateral hip implant
- • 5. Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e., no fixed address, mentally competent to give consent, etc.)
- • 6. Non-ambulatory patients
- • 7. Multi-trauma patient (Injury Severity Score ≥ 16)
- • 8. Lack of bone substance or poor bone-quality which, in the surgeon's judgment, makes fixation impossible
- • 9. Any concomitant lower-extremity injury
- • 10. Inability to obtain informed consent due to language barrier
About London Health Sciences Centre Research Institute Or Lawson Research Institute Of St. Joseph's
The London Health Sciences Centre Research Institute, affiliated with Lawson Health Research Institute at St. Joseph's Health Care, is dedicated to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into practical applications, the institute fosters collaboration among leading researchers, clinicians, and healthcare professionals. It aims to improve patient outcomes and enhance the quality of care through rigorous investigation in areas such as cancer, cardiovascular health, and neuroscience. By integrating cutting-edge research with clinical practice, the institute plays a pivotal role in shaping the future of healthcare delivery in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
New Westminster, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported